Genmab A/S – admittance to trading and official listing of new shares due to employee warrant exercise

        Print
| Source: NASDAQ OMX Copenhagen A/S
multilang-release

The share capital of Genmab A/S has been increased. The admittance to trading and official listing will take effect as per 18 March 2014 in the ISIN below.

We refer to the announcements published by Genmab.

 

ISIN: DK0010272202
Name: Genmab
Volume before change: 56,355,722 shares (DKK 56,355,722)
Change: 273,480 shares (DKK 273,480)
Volume after change: 56,629,202shares (DKK 56,629,202)
Subscription prices: 6,250 shares at DKK 31.75
750 shares at DKK 45.24,
16,125 shares at DKK 46.74
2,750 shares at DKK 55.85
14,700 shares at DKK 66.60
4,225 shares at DKK 67.50
6,500 shares at DKK 68.65
500 shares at DKK 77
750 shares at DKK 79.25
30,875 shares at DKK 80.55
47,350 shares at DKK 86
2,000 shares at DKK 89.50
7,700 shares at DKK 97
437 shares at DKK 98
23,812 shares at DKK 101
36,925 shares at DKK 114
2,250 shares at DKK 116
43,280 shares at DKK 129.75
4,375 shares at DKK 130
2,875 shares at DKK 173
11,500 shares at DKK 174
3,563 shares at DKK 184
3,988 shares at DKK 210.50
Face value: DKK 1
Short name: GEN
Orderbook ID: 11143

  

For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33 93 33 66